11 results on '"Agerstrand M"'
Search Results
2. The Swedish Environmental Classification and Information System for Pharmaceuticals — An empirical investigation of the motivations, intentions and expectations underlying its development and implementation
- Author
-
Ågerstrand, M., Wester, M., and Rudén, C.
- Published
- 2009
- Full Text
- View/download PDF
3. The role of behavioral ecotoxicology in environmental protection
- Author
-
Ford, AT, Agerstrand, M, Brooks, BW, Allen, J, Bertram, MG, Brodin, T, Dang, Z, Duquesne, S, Sahm, R, and Smit, E
- Published
- 2021
4. The NORMAN Association and the European Partnership for Chemicals Risk Assessment (PARC): let’s cooperate!
- Author
-
Dulio, V. Koschorreck, J. van Bavel, B. van den Brink, P. Hollender, J. Munthe, J. Schlabach, M. Aalizadeh, R. Agerstrand, M. Ahrens, L. Allan, I. Alygizakis, N. Barcelo’, D. Bohlin-Nizzetto, P. Boutroup, S. Brack, W. Bressy, A. Christensen, J.H. Cirka, L. Covaci, A. Derksen, A. Deviller, G. Dingemans, M.M.L. Engwall, M. Fatta-Kassinos, D. Gago-Ferrero, P. Hernández, F. Herzke, D. Hilscherová, K. Hollert, H. Junghans, M. Kasprzyk-Hordern, B. Keiter, S. Kools, S.A.E. Kruve, A. Lambropoulou, D. Lamoree, M. Leonards, P. Lopez, B. López de Alda, M. Lundy, L. Makovinská, J. Marigómez, I. Martin, J.W. McHugh, B. Miège, C. O’Toole, S. Perkola, N. Polesello, S. Posthuma, L. Rodriguez-Mozaz, S. Roessink, I. Rostkowski, P. Ruedel, H. Samanipour, S. Schulze, T. Schymanski, E.L. Sengl, M. Tarábek, P. Ten Hulscher, D. Thomaidis, N. Togola, A. Valsecchi, S. van Leeuwen, S. von der Ohe, P. Vorkamp, K. Vrana, B. Slobodnik, J.
- Abstract
The Partnership for Chemicals Risk Assessment (PARC) is currently under development as a joint research and innovation programme to strengthen the scientific basis for chemical risk assessment in the EU. The plan is to bring chemical risk assessors and managers together with scientists to accelerate method development and the production of necessary data and knowledge, and to facilitate the transition to next-generation evidence-based risk assessment, a non-toxic environment and the European Green Deal. The NORMAN Network is an independent, well-established and competent network of more than 80 organisations in the field of emerging substances and has enormous potential to contribute to the implementation of the PARC partnership. NORMAN stands ready to provide expert advice to PARC, drawing on its long experience in the development, harmonisation and testing of advanced tools in relation to chemicals of emerging concern and in support of a European Early Warning System to unravel the risks of contaminants of emerging concern (CECs) and close the gap between research and innovation and regulatory processes. In this commentary we highlight the tools developed by NORMAN that we consider most relevant to supporting the PARC initiative: (i) joint data space and cutting-edge research tools for risk assessment of contaminants of emerging concern; (ii) collaborative European framework to improve data quality and comparability; (iii) advanced data analysis tools for a European early warning system and (iv) support to national and European chemical risk assessment thanks to harnessing, combining and sharing evidence and expertise on CECs. By combining the extensive knowledge and experience of the NORMAN network with the financial and policy-related strengths of the PARC initiative, a large step towards the goal of a non-toxic environment can be taken. © 2020, The Author(s).
- Published
- 2020
5. The NORMAN Association and the European Partnership for Chemicals Risk Assessment (PARC): let’s cooperate!
- Author
-
Dulio, V., Koschorreck, J., van Bavel, B., van den Brink, P., Hollender, J., Munthe, J., Schlabach, M., Aalizadeh, R., Agerstrand, M., Ahrens, L., Allan, I., Alygizakis, N., Barcelo, D., Bohlin‑Nizzetto, P., Boutroup, S., Brack, Werner, Bressy, A., Christensen, J.H., Cirka, L., Covaci, A., Derksen, A., Deviller, G., Dingemans, M.M.L., Engwall, M., Fatta-Kassinos, D., Gago‑Ferrero, P., Hernández, F., Herzke, D., Hilscherová, K., Hollert, H., Junghans, M., Kasprzyk‑Hordern, B., Keiter, S., Kools, S.A.E., Kruve, A., Lambropoulou, D., Lamoree, M., Leonards, P., Lopez, B., López de Alda, M., Lundy, L., Makovinská, J., Marigómez, I., Martin, J.W., McHugh, B., Miège, C., O’Toole, S., Perkola, N., Polesello, S., Posthuma, L., Rodriguez‑Mozaz, S., Roessink, I., Rostkowski, P., Ruedel, H., Samanipour, S., Schulze, Tobias, Schymanski, E.L., Sengl, M., Tarábek, P., Ten Hulscher, D., Thomaidis, N., Togola, A., Valsecchi, S., van Leeuwen, S., von der Ohe, P., Vorkamp, K., Vrana, B., Slobodnik, J., Dulio, V., Koschorreck, J., van Bavel, B., van den Brink, P., Hollender, J., Munthe, J., Schlabach, M., Aalizadeh, R., Agerstrand, M., Ahrens, L., Allan, I., Alygizakis, N., Barcelo, D., Bohlin‑Nizzetto, P., Boutroup, S., Brack, Werner, Bressy, A., Christensen, J.H., Cirka, L., Covaci, A., Derksen, A., Deviller, G., Dingemans, M.M.L., Engwall, M., Fatta-Kassinos, D., Gago‑Ferrero, P., Hernández, F., Herzke, D., Hilscherová, K., Hollert, H., Junghans, M., Kasprzyk‑Hordern, B., Keiter, S., Kools, S.A.E., Kruve, A., Lambropoulou, D., Lamoree, M., Leonards, P., Lopez, B., López de Alda, M., Lundy, L., Makovinská, J., Marigómez, I., Martin, J.W., McHugh, B., Miège, C., O’Toole, S., Perkola, N., Polesello, S., Posthuma, L., Rodriguez‑Mozaz, S., Roessink, I., Rostkowski, P., Ruedel, H., Samanipour, S., Schulze, Tobias, Schymanski, E.L., Sengl, M., Tarábek, P., Ten Hulscher, D., Thomaidis, N., Togola, A., Valsecchi, S., van Leeuwen, S., von der Ohe, P., Vorkamp, K., Vrana, B., and Slobodnik, J.
- Abstract
The Partnership for Chemicals Risk Assessment (PARC) is currently under development as a joint research and innovation programme to strengthen the scientific basis for chemical risk assessment in the EU. The plan is to bring chemical risk assessors and managers together with scientists to accelerate method development and the production of necessary data and knowledge, and to facilitate the transition to next-generation evidence-based risk assessment, a non-toxic environment and the European Green Deal. The NORMAN Network is an independent, well-established and competent network of more than 80 organisations in the field of emerging substances and has enormous potential to contribute to the implementation of the PARC partnership. NORMAN stands ready to provide expert advice to PARC, drawing on its long experience in the development, harmonisation and testing of advanced tools in relation to chemicals of emerging concern and in support of a European Early Warning System to unravel the risks of contaminants of emerging concern (CECs) and close the gap between research and innovation and regulatory processes. In this commentary we highlight the tools developed by NORMAN that we consider most relevant to supporting the PARC initiative: (i) joint data space and cutting-edge research tools for risk assessment of contaminants of emerging concern; (ii) collaborative European framework to improve data quality and comparability; (iii) advanced data analysis tools for a European early warning system and (iv) support to national and European chemical risk assessment thanks to harnessing, combining and sharing evidence and expertise on CECs. By combining the extensive knowledge and experience of the NORMAN network with the financial and policy-related strengths of the PARC initiative, a large step towards the goal of a non-toxic environment can be taken.
- Published
- 2020
6. How we can make ecotoxicology more valuable to environmental protection
- Author
-
Hanson, M.L., Wolff, B.A., Green, J.W., Kivi, M., Panter, G.H., Warne, M.St.J., Ågerstrand, M., and Sumpter, J.P.
- Published
- 2017
- Full Text
- View/download PDF
7. The essential elements of a risk governance framework for current and future nanotechnologies
- Author
-
Stone, V., Führer, M., Feindt, P.H., Bouwmeester, H., Linkov, I., Sabella, S., Murphy, F., Bizer, K., Tran, L., Agerstrand, M., Fito, C., Andersen, T., Anderson, D., Bergamaschi, E., Cherrie, J.W., Cowan, S., Dalemcourt, J.-F., Faure, Michael, Gabbert, S., Gajewicz, A., Fernandes, T.F., Hristozov, D., Johnston, H.J., Lansdown, T.C., Linder, S., Marvin, H.J.P., Mullins, M., Purnhagen, K.P., Puzyn, T., Sanchez Jimenez, A., Scott-Fordsmand, J.J., Streftaris, G., van Tongeren, M., Voelcker, N.H., Voyiatzis, G., Yannopoulos, S.N., Poortvliet, P.M., Stone, V., Führer, M., Feindt, P.H., Bouwmeester, H., Linkov, I., Sabella, S., Murphy, F., Bizer, K., Tran, L., Agerstrand, M., Fito, C., Andersen, T., Anderson, D., Bergamaschi, E., Cherrie, J.W., Cowan, S., Dalemcourt, J.-F., Faure, Michael, Gabbert, S., Gajewicz, A., Fernandes, T.F., Hristozov, D., Johnston, H.J., Lansdown, T.C., Linder, S., Marvin, H.J.P., Mullins, M., Purnhagen, K.P., Puzyn, T., Sanchez Jimenez, A., Scott-Fordsmand, J.J., Streftaris, G., van Tongeren, M., Voelcker, N.H., Voyiatzis, G., Yannopoulos, S.N., and Poortvliet, P.M.
- Abstract
Societies worldwide are investing considerable resources into the safe development and use of nanomaterials. Although each of these protective efforts is crucial for governing the risks of nanomaterials, they are insufficient in isolation. What is missing is a more integrative governance approach that goes beyond legislation. Development of this approach must be evidence based and involve key stakeholders to ensure acceptance by end users. The challenge is to develop a framework that coordinates the variety of actors involved in nanotechnology and civil society to facilitate consideration of the complex issues that occur in this rapidly evolving research and development area. Here, we propose three sets of essential elements required to generate an effective risk governance framework for nanomaterials. (1) Advanced tools to facilitate risk-based decision making, including an assessment of the needs of users regarding risk assessment, mitigation, and transfer. (2) An integrated model of predicted human behavior and decision making concerning nanomaterial risks. (3) Legal and other (nano-specific and general) regulatory requirements to ensure compliance and to stimulate proactive approaches to safety. The implementation of such an approach should facilitate and motivate good practice for the various stakeholders to allow the safe and sustainable future development of nanotechnology.
- Published
- 2018
8. Towards the review of the European Union Water Framework Directive: Recommendations for more efficient assessment and management of chemical contamination in European surface water resources
- Author
-
Brack, W., Dulio, V., Agerstrand, M., Allan, I., Altenburger, R., Brinkmann, M., Bunke, D., Burgess, R.M., Cousins, I., Escher, B.I., Hernandez, F.J., Hewitt, L.M., Hilscherova, K., Hollender, J., Hollert, H., Kase, R., Klauer, B., Lindim, C., Herraez, D.L., Miege, C., Munthe, J., O'Toole, S., Posthuma, L., Rudel, H., Schafer, R.B., Sengl, M., Smedes, F., van de Meent, D., van den Brink, P.J., van Gils, J., van Wezel, A.P., Vethaak, A.D., Vermeirssen, E., von der Ohe, P.C., Vrana, B., Brack, W., Dulio, V., Agerstrand, M., Allan, I., Altenburger, R., Brinkmann, M., Bunke, D., Burgess, R.M., Cousins, I., Escher, B.I., Hernandez, F.J., Hewitt, L.M., Hilscherova, K., Hollender, J., Hollert, H., Kase, R., Klauer, B., Lindim, C., Herraez, D.L., Miege, C., Munthe, J., O'Toole, S., Posthuma, L., Rudel, H., Schafer, R.B., Sengl, M., Smedes, F., van de Meent, D., van den Brink, P.J., van Gils, J., van Wezel, A.P., Vethaak, A.D., Vermeirssen, E., von der Ohe, P.C., and Vrana, B.
- Abstract
Item does not contain fulltext, Water is a vital resource for natural ecosystems and human life, and assuring a high quality of water and protecting it from chemical contamination is a major societal goal in the European Union. The Water Framework Directive (WFD) and its daughter directives are the major body of legislation for the protection and sustainable use of European freshwater resources. The practical implementation of the WFD with regard to chemical pollution has faced some challenges. In support of the upcoming WFD review in 2019 the research project SOLUTIONS and the European monitoring network NORMAN has analyzed these challenges, evaluated the state-of-the-art of the science and suggested possible solutions. We give 10 recommendations to improve monitoring and to strengthen comprehensive prioritization, to foster consistent assessment and to support solution-oriented management of surface waters. The integration of effect-based tools, the application of passive sampling for bioaccumulative chemicals and an integrated strategy for prioritization of contaminants, accounting for knowledge gaps, are seen as important approaches to advance monitoring. Including all relevant chemical contaminants in more holistic "chemical status" assessment, using effect-based trigger values to address priority mixtures of chemicals, to better consider historical burdens accumulated in sediments and to use models to fill data gaps are recommended for a consistent assessment of contamination. Solution-oriented management should apply a tiered approach in investigative monitoring, to identify toxicity drivers, strengthen consistent legislative frameworks and apply solutions-oriented approaches that explore risk reduction scenarios before and along with risk assessment. (C) 2016 Published by Elsevier B.V.
- Published
- 2017
9. The Swedish Environmental Classification and Information System for Pharmaceuticals--an empirical investigation of the motivations, intentions and expectations underlying its development and implementation.
- Author
-
Agerstrand, M, Wester, M, Rudén, C, Agerstrand, M, Wester, M, and Rudén, C
- Abstract
In 2005 the Swedish Association of the Pharmaceutical Industry (LIF) initiated a national environmental classification and information system for pharmaceuticals. This investigation reports the results from a survey, conducted among the persons involved in the start-up process. The aim of this study is to generate knowledge contributing to the clarification of the motivations, expectations, and intentions underlying the development and implementation of the system. The decision to implement a classification and information system for pharmaceuticals was the result of a combination of several driving forces, mainly political pressure and a possibility to increase the industries' goodwill, while at the same time keeping the process under the industries' control. The expected possible effects of the system, other than increased goodwill, are according to this survey assumed to be low. The system offers little guidance for end-users in the substitution of one pharmaceutical for another. One possible reason for this could be that LIF needs to observe the interests of all its members' and should not affect competition. The affiliation of the involved actors correlates to how these actors view and value the system, but this has not hampered the collaborative process to develop and implement it.
- Published
- 2009
- Full Text
- View/download PDF
10. A proposed framework for the systematic review and integrated assessment (SYRINA) of endocrine disrupting chemicals
- Author
-
Vandenberg, LN, Ågerstrand, M, Beronius, A, Beausoleil, C, Bergman, Å, Bero, LA, Bornehag, CG, Boyer, CS, Cooper, GS, Cotgreave, I, Gee, D, Grandjean, Philippe, Guyton, KZ, Hass, U, Heindel, JJ, Jobling, S, Kidd, KA, Kortenkamp, A, Macleod, MR, Martin, OV, Norinder, U, Scheringer, M, Thayer, KA, Toppari, J, Whaley, P, Woodruff, TJ, and Rudén, C
- Abstract
Background: The issue of endocrine disrupting chemicals (EDCs) is receiving wide attention from both the scientific and regulatory communities. Recent analyses of the EDC literature have been criticized for failing to use transparent C exposures to adverse health or environmental outcomes. Systematic review methodologies are ideal for addressing this issue as they provide transparent and consistent approaches to study selection and evaluation. Objective methods are needed for integrating the multiple streams of evidence (epidemiology, wildlife, laboratory animal, in vitro, and in silico data) that are relevant in assessing EDCs. Methods: We have developed a framework for the systematic review and integrated assessment (SYRINA) of EDC studies. The framework was designed for use with the International Program on Chemical Safety (IPCS) and World Health Organization (WHO) definition of an EDC, which requires appraisal of evidence regarding 1) association between exposure and an adverse effect, 2) association between exposure and endocrine disrupting activity, and 3) a plausible link between the adverse effect and the endocrine disrupting activity. Results: Building from existing methodologies for evaluating and synthesizing evidence, the SYRINA framework includes seven steps: 1) Formulate the problem; 2) Develop the review protocol; 3) Identify relevant evidence; 4) Evaluate evidence from individual studies; 5) Summarize and evaluate each stream of evidence; 6) Integrate evidence across all streams; 7) Draw conclusions, make recommendations, and evaluate uncertainties. The proposed method is tailored to the IPCS/WHO definition of an EDC but offers flexibility for use in the context of other definitions of EDCs. Conclusions: When using the SYRINA framework, the overall objective is to provide the evidence base needed to support decision making, including any action to avoid/minimise potential adverse effects of exposures. This framework allows for the evaluation and synthesis of evidence from multiple evidence streams. Finally, a decision regarding regulatory action is not only dependent on the strength of evidence, but also the consequences of action/inaction, e.g. limited or weak evidence may be sufficient to justify action if consequences are serious or irreversible.
- Published
- 2016
- Full Text
- View/download PDF
11. Evaluation of the accuracy and consistency of the Swedish environmental classification and information system for pharmaceuticals.
- Author
-
Agerstrand M and Rudén C
- Subjects
- Environmental Monitoring, Environmental Pollutants analysis, Environmental Pollutants classification, Pharmaceutical Preparations analysis, Pharmaceutical Preparations classification, Reproducibility of Results, Risk Assessment, Sweden, Voluntary Programs, Drug-Related Side Effects and Adverse Reactions, Environmental Exposure prevention & control, Environmental Pollutants adverse effects, National Health Programs
- Abstract
The Swedish environmental and classification system for pharmaceuticals is a voluntary, industry-owned system with the purpose to provide environmental information about active pharmaceutical ingredients in the Swedish market. In this paper we report the results from a detailed evaluation of the accuracy and consistency of the risk assessments conducted within this system. The evaluation focused on the following three aspects: 1) comparison of the companies' risk assessments with the classification system's own guidance document, 2) how the risk assessments are affected if additional effect data is used, and 3) the consistency of different risk assessments for the same pharmaceutical substance. The analyses show that the system's guidance gives no criteria for when to consider a study "long-term" or "short-term", and that this confusion affected the outcome of the risk assessments in some cases. Furthermore, when the system's guidance document is followed and the risk assessment was supplemented with effect data from the open scientific literature, then the risk classification for a substantial number of the evaluated substances was altered. Our analyses also revealed that in some cases risk assessors disagree on the outcome of the assessment for the same active pharmaceutical ingredient. Finally we list some recommendations to improve the classification system. The recommendations include clarifying concepts and instructions in the guidance document, introduction of a standardized way of reporting data to the website, and promotion of use of non-standard test data when considered the most relevant., (Copyright 2010 Elsevier B.V. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.